CMRXEUR

Chimerix, Inc.

A biopharmaceutical company in Durham, North Carolina, that develops medicines for serious diseases. Founded in 2000, it made its name on lipid-conjugated antivirals — its smallpox drug Tembexa attached fat molecules to an existing antiviral to help it reach cells. It later pivoted to brain cancer, winning 2025 FDA approval for Modeyso, a therapy for a rare childhood brain tumor, before being bought by Jazz Pharmaceuticals. Its name blends "chimera," a creature of mixed parts, with an "x" for experiment.

No proxy statement recorded.